Questioning Medicine

Questioning Medicine

Health EN ↓ 392 episodes

Join Andrew on a medical rollercoaster as we ask a medical question and answer it based on recent published papers.  

Author

Questioning Medicine

Category

Health

Podcast website

www.podomatic.com

Latest episode

Jul 8, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Episode 380: 391. Hospital Medicine Electrolyte Abnormalities - CME 05.04.2025

CME

Episode 379: 390. Hospital Medicine- AKI CME 04.04.2025

FREE CME KNOWLEDGE

Episode 378: 389. Stroke- Admit to Discharge. CME 19.03.2025

Free CME

Episode 377: 388. ACOI COPD and PNA 19.03.2025

CME for FREE

Episode 376: 387. Methods Monday and an Example of Subgroup Analysis 17.03.2025

https://www.nejm.org/doi/full/10.1056/NEJMoa2405923?query=clinical-medicine   Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial after myocardial infarction is uncertain.     Recent attempts to improve outcomes with intensified renin–angiotensin–aldoste...

Episode 375: 386. Could half dose anticoagulation be the answer? 14.03.2025

Estimated 5-year incidence of recurrent VTE was similar in the reduced-dose and full-dose groups (2.2% and 1.8%). Estimated 5-year bleeding incidence was significantly lower with reduced-dose than with full-dose treatment (2.1% vs. 4.0% for major bleeding; 8.6% vs. 11.5% for clinically relevant nonmajor bleeding). Outcomes with apixaban and rivaroxaban were similar. Couturaud F et al. Extended tre...

Episode 374: 385. PRACTICE CHANGER! Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis 12.03.2025

https://www.nejm.org/doi/full/10.1056/NEJMoa2405404 NNT of 4! systemic metronid and topical clinda bid for one week

Episode 373: 384. Chronic Kidney Disease and Empagliflozin Legacy Effect 11.03.2025

What Was Studied? The EMPA-KIDNEY trial followed 6,609 CKD patients at risk of disease progression. Participants were randomly assigned to receive empagliflozin (10 mg daily) or a placebo for a median of 2 years. After this ‘active’ phase, 4,891 patients entered a 2-year post-trial observational period where neither group received the trial drug, but doctors could prescribe open-label SGLT2 inhibi...

Episode 372: 383. What is the GFR at which we stop metforin? 06.03.2025

Metformin while not necessarily first line therapy for diabetes depending on the patients co-morbid conditions it is certainly highly ranked on the list of medications!   I know often metformin is stopped while coming into the hospital for fear of potentially lactic acidosis or an increase in AKI with contrast studies however this ‘belief’ is largely based on myth and misconception. Metformin's co...

Episode 371: 382. Is it safe to give the flu and covid vaccine at the same time? 04.03.2025

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825813 Conclusions and Relevance   In this randomized clinical trial assessing simultaneous vs sequential administration of mRNA COVID-19 and IIV4 vaccines, reactogenicity was comparable in both groups. These findings support the option of simultaneous administration of these vaccines.

Episode 370: 381. Relative efficacy of prehabilitation interventions and their components 27.02.2025

https://www.bmj.com/content/388/bmj-2024-081164 systematic review and meta-analysis on prehabilitation before surgery, published in the BMJ in February 2025.Prehabilitation aims to prepare patients for surgery through interventions like exercise, nutrition, and psychological support. This study looked at which prehabilitation components are most effective for improving key outcomes after surgery....

Episode 369: 380. REPOST mammo part 2 24.02.2025

Mammograms

Episode 368: 379. REPOST mammogram part 1 18.02.2025

379. REPORT mammogram part 1

Episode 367: 378. What is the Best Way To Treat Ductal Carcinoma In Situ 12.02.2025

https://jamanetwork.com/journals/jama/article-abstract/2828218 DCIS is a non-invasive form of breast cancer, meaning the abnormal cells are contained within the milk ducts. For years, the standard treatment has been surgery, often followed by radiation and/or hormone therapy - the same treatments used for invasive breast cancer. But is this aggressive approach always necessary for low-risk DCIS? (...

Episode 366: 377. Does How Long You Have Hypertension Matter? 11.02.2025

Association of Duration of Recognized Hypertension and Stroke Risk: The REGARDS Study       (Transition Music - Short and subtle - 2 seconds)Host:    Hypertension is a well-known risk factor for stroke, but this study, led by Dr. George Howard and colleagues, asks a fascinating question: Does the duration of hypertension matter, even when blood pressure is managed?   (Transition Music - Short and...

Episode 365: 366. Association of dose of inhaled corticosteroids and frequency of adverse events 07.02.2025

Bloom CI et al. Association of dose of inhaled corticosteroids and frequency of adverse events. Am J Respir Crit Care Med 2025 Jan; 211:54. ( https://doi.org/10.1164/rccm.202402-0368OC )     Bloom and colleagues' study, published in the American Journal of Respiratory and Critical Care Medicine in January 2025, provides significant insights into the safety profile of inhaled corticosteroids (ICS)...

Episode 364: 364. The safety and efficacy of sodium–glucose cotransporter 2 inhibitor in hospitalized patients 04.02.2025

Gao FM et al. A systematic review and meta-analysis on the safety and efficacy of sodium–glucose cotransporter 2 inhibitor use in hospitalized patients. Diabetes Care 2024 Dec 1; 47:2275. ( https://doi.org/10.2337/dc24-0946 )   Trial Results SGLT-2 inhibitors, crucial in managing diabetes, kidney disease, and heart failure, have shown promising results in hospitalized patients 1 . The meta-analysi...

Episode 363: 262. Myocardial injury in patients with hip fracture 31.01.2025

Is accelerated surgery for hip fracture better for high-risk patients?   A recent substudy of the HIP ATTACK trial has shed new light on this topic. The original trial, published in 2020, compared accelerated surgery (within 6 hours) to standard-timing surgery (within 24 hours) for hip fracture patients. While the initial results showed only marginal benefits, this new analysis focuses on a specif...

Episode 362: 261. What to do with the beta blocker following a Myocardial Infarction 15.01.2025

Today, we're discussing two groundbreaking studies from 2024 that challenge our understanding of β-blocker therapy for secondary prevention after myocardial infarction, or MI.Let's start with a Swedish study Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction | New England Journal of Medicine that included over 5,000 patients with normal left ventricular ejection fraction aft...

Episode 361: 260. METHODS MONDAY-- EVENT RATE 13.01.2025

Methods Monday  --- Accuracy of Event Rate and Effect Size Estimation in Major Cardiovascular Trials: A Systematic Review | Cardiology | JAMA Network Open | JAMA Network     During the design of a randomized clinical trial (RCT), estimation of the expected event rate and effect size is a key component to calculating the sample size. Overly optimistic estimation of event rates and effect sizes may...

Episode 360: 259. Urinary Retention Evaluation and Catheterization Algorithm for Adult Inpatients 10.01.2025

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2821168 A team of researchers set out to change that by developing a comprehensive algorithm. The process involved a multidisciplinary panel of 11 expertss with extensive experience in managing urinary retention. These experts evaluated about 100 clinical scenarios to create an initial flow sheet. The algorithm was then refined through i...

Episode 359: 258. Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions 03.01.2025

https://jamanetwork.com/journals/jama/article-abstract/2822097 Design, Setting, and Participants   Nested case-control study using population-based linked administrative datasets among adults aged 66 years or older who received at least 1 oral antibiotic between 2002 and 2022 in Ontario, Canada. Cases were those who had an emergency department (ED) visit or hospitalization for serious cADRs within...

Episode 358: 257. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention 30.12.2024

https://www.nejm.org/doi/full/10.1056/NEJMoa2407001 Conclusions No participants receiving twice-yearly lenacapavir acquired HIV infection. HIV incidence with lenacapavir was significantly lower than background HIV incidence and HIV incidence with F/TDF.  Among 5338 participants who were initially HIV-negative, 55 incident HIV infections were observed: 0 infections among 2134 participants in the le...

Episode 357: 256. Medications for alcohol-use disorder and follow-up after hospitalization 27.12.2024

Allaudeen N et al. Medications for alcohol-use disorder and follow-up after hospitalization for alcohol withdrawal: A multicenter study. J Hosp Med 2024 Dec; 19:1122. ( https://doi.org/10.1002/jhm.13458 )       Hospital admission for alcohol withdrawal is a problem when it comes to readmission. They just come back---   In this retrospective study of ≈600 patients (96% men) admitted for alcohol wit...

Episode 356: 255. Real-world use of glucocorticoids for adults hospitalized with community-acquired pneumonia 23.12.2024

Real‐world use of glucocorticoids and clinical outcomes in adults hospitalized with community‐acquired pneumonia on medical wards - Malecki - 2024 - Journal of Hospital Medicine - Wiley Online Library   This was a retrospective cohort study of 11,500 patients with CAP who were admitted to general medicine units in 7 Canadian hospitals, researchers compared outcomes for patients who received system...

Listen to the Questioning Medicine podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.